FR2823M - - Google Patents
Download PDFInfo
- Publication number
- FR2823M FR2823M FR914736A FR914736A FR2823M FR 2823 M FR2823 M FR 2823M FR 914736 A FR914736 A FR 914736A FR 914736 A FR914736 A FR 914736A FR 2823 M FR2823 M FR 2823M
- Authority
- FR
- France
- Prior art keywords
- iron
- glucoheptonate
- animals
- rats
- batch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 70
- 229910052742 iron Inorganic materials 0.000 description 34
- FATUQANACHZLRT-KMRXSBRUSA-L calcium glucoheptonate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C([O-])=O FATUQANACHZLRT-KMRXSBRUSA-L 0.000 description 28
- 241001465754 Metazoa Species 0.000 description 21
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 19
- 241000700159 Rattus Species 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 11
- 239000008187 granular material Substances 0.000 description 10
- 235000010323 ascorbic acid Nutrition 0.000 description 8
- 239000011668 ascorbic acid Substances 0.000 description 8
- 229960005070 ascorbic acid Drugs 0.000 description 8
- 235000005911 diet Nutrition 0.000 description 8
- 230000037213 diet Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 206010022971 Iron Deficiencies Diseases 0.000 description 6
- 239000000829 suppository Substances 0.000 description 6
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 5
- 208000007502 anemia Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 241000700198 Cavia Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- OWZIYWAUNZMLRT-UHFFFAOYSA-L iron(2+);oxalate Chemical compound [Fe+2].[O-]C(=O)C([O-])=O OWZIYWAUNZMLRT-UHFFFAOYSA-L 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 240000007651 Rubus glaucus Species 0.000 description 2
- 235000011034 Rubus glaucus Nutrition 0.000 description 2
- 235000009122 Rubus idaeus Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 231100000456 subacute toxicity Toxicity 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 231100000041 toxicology testing Toxicity 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000022440 X-linked sideroblastic anemia 1 Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
- 235000020440 raspberry syrup Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/10—Polyhydroxy carboxylic acids
- C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR914736A FR2823M (en, 2012) | 1962-11-08 | 1962-11-08 | |
| BE639403A BE639403A (fr) | 1962-11-08 | 1963-10-31 | Gluco-heptonate de fer. |
| GB43503/63A GB1023342A (en) | 1962-11-08 | 1963-11-04 | A new iron salt and pharmaceutical compositions thereof |
| ES0293574A ES293574A1 (es) | 1962-11-08 | 1963-11-07 | Procedimiento de preparaciën del glucoheptonato de hierro |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR914736A FR2823M (en, 2012) | 1962-11-08 | 1962-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2823M true FR2823M (en, 2012) | 1964-11-06 |
Family
ID=8790355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR914736A Expired FR2823M (en, 2012) | 1962-11-08 | 1962-11-08 |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE639403A (en, 2012) |
| ES (1) | ES293574A1 (en, 2012) |
| FR (1) | FR2823M (en, 2012) |
| GB (1) | GB1023342A (en, 2012) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1183940A (en) * | 1966-10-22 | 1970-03-11 | Fisons Pharmaceuticals Ltd | Ferric Hydroxide Complexes |
| CN110776416A (zh) * | 2019-11-08 | 2020-02-11 | 上海永通生态工程股份有限公司 | 一种葡庚糖酸铁的制备方法 |
-
1962
- 1962-11-08 FR FR914736A patent/FR2823M/fr not_active Expired
-
1963
- 1963-10-31 BE BE639403A patent/BE639403A/fr unknown
- 1963-11-04 GB GB43503/63A patent/GB1023342A/en not_active Expired
- 1963-11-07 ES ES0293574A patent/ES293574A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1023342A (en) | 1966-03-23 |
| ES293574A1 (es) | 1964-03-16 |
| BE639403A (fr) | 1964-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0287488B1 (fr) | Médicament, produit diététique et produit d'hygiène sous la forme d'une composition pulvérulente obtenue par adsorption de principes actifs sur un sucre à dissolution rapide et procédé d'obtention de ladite composition | |
| KR100685696B1 (ko) | 활성 성분으로 조효소 ｑ를 함유하는 경점막 투여용 조성물 | |
| LU86901A1 (fr) | Compositions pharmaceutiques de polypeptides adaptees a la resorption gastro-intestinale | |
| FR2505184A1 (fr) | Procede de prevention de la paralysie vitulaire chez la vache laitiere | |
| FR2823M (en, 2012) | ||
| CA1226522A (fr) | Composition de mineraux injectables a usage veterinaire | |
| EP1358159B1 (fr) | Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations | |
| WO1995033444A1 (fr) | Composition therapeutique ou dietetique sous forme de gel medicamenteux pour l'administration a des animaux de compagnie | |
| EP3242674B1 (fr) | Compositions contenant de la curcumine à biodisponibilité améliorée | |
| EP0113608A1 (fr) | Association permettant d'améliorer l'absorption de divers cations | |
| EP1317922B1 (fr) | Preparation antipyretique renfermant du xylitol | |
| BE1004243A3 (fr) | Compositions pharmaceutiques du type a liberation prolongee destinees a l'administration par voie orale et leur procede de preparation. | |
| JP3096052B2 (ja) | 脂質代謝調節剤 | |
| FR2557797A1 (fr) | Composition therapeutique a base de terminalia chebula pour le traitement du psoriasis par voie orale. | |
| FR2619313A1 (fr) | Nouvelles compositions d'elements mineraux et/ou oligoelements et leur procede de preparation | |
| EP0086680B1 (fr) | Nouvelles compositons à effet antiasthénique puissant à base de sels doubles de l'acide ascorbique et d'un diacide amine | |
| CA1221635A (fr) | Composition a activite pharmaceutique amelioree et utilisation de celle-ci pour des usages veterinaires | |
| FR2547730A1 (fr) | Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie | |
| CA1187785A (fr) | Medicament a base de l-methionine | |
| CH667391A5 (fr) | Compositions pharmaceutiques pour le traitement de colites et colopathies. | |
| EP0412877A1 (fr) | Nouvelle forme galénique orale améliorant la biodisponibilité | |
| EP0766692B1 (fr) | Derives de l'acide guanylique et applications comme medicaments | |
| EP0295166A1 (fr) | Compositions pharmaceutiques contenant un mélange de sels de cétoacides et d'amino-acides | |
| EP0027768A1 (fr) | Nouvelles résines échangeuses d'ions du type acide, leur préparation, leur application comme médicaments et les compositions les renfermant | |
| FR2531337A1 (fr) | Nouvelles formes galeniques administrables par voie orale, des derives de la dimethylxanthine solubles |